Carl Zeiss Meditec AG
CZMWFOTCHealthcare● Active
$30.70
+$1.53(+5.25%)
Market Cap$2.7B
P/E Ratio—
52W High$70.75
52W Low$26.42
Carl Zeiss Meditec AG (CZMWF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CZMWF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
$0.38
Revenue
$1.14B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
CZMWF reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.20
Rev. $3.50B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.20
Rev. Est.$3.50B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2026 | Dec 10, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Aug 6, 2026 | $1.37 | — | — | — | $0.65B | — |
| — Q2 FY2026 | May 12, 2026 | — | $0.38 | — | $1.14B | — | — |
| ▼ Q2 FY2026 | May 12, 2026 | $0.56 | $0.20 | -64.7% | $1.14B | $1.14B | +0.0% |
| ◌ Q1 FY2026 | Feb 12, 2026 | $1.25 | — | — | — | $0.62B | — |
| — Q3 FY2025 | Aug 7, 2025 | — | $0.38 | — | $0.65B | $0.70B | -7.2% |
| ▲ Q2 FY2025 | May 13, 2025 | $0.46 | $0.58 | +26.9% | $0.61B | $0.59B | +3.9% |
| — Q1 FY2025 | Feb 7, 2025 | — | $0.19 | — | $0.51B | $0.56B | -8.7% |
Q4 FY2026
Dec 10, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$1.37
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026
EPS Actual
$0.38
EPS Est.
—
EPS Surpr.
—
Revenue
$1.14B
Q2 FY2026
May 12, 2026Miss
EPS Actual
$0.20
EPS Est.
$0.56
EPS Surpr.
-64.7%
Revenue
$1.14B
Q1 FY2026
Feb 12, 2026
EPS Actual
—
EPS Est.
$1.25
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 7, 2025
EPS Actual
$0.38
EPS Est.
—
EPS Surpr.
—
Revenue
$0.65B
Q2 FY2025
May 13, 2025Beat
EPS Actual
$0.58
EPS Est.
$0.46
EPS Surpr.
+26.9%
Revenue
$0.61B
Q1 FY2025
Feb 7, 2025
EPS Actual
$0.19
EPS Est.
—
EPS Surpr.
—
Revenue
$0.51B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $1.17 | $1.19 | $1.21 | 1 |
| Q2 FY2026 | $1.17 | $1.19 | $1.21 | 1 |
| Q1 FY2026 | $1.07 | $1.09 | $1.11 | 1 |
| Q4 FY2025 | $1.05 | $1.06 | $1.08 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 1 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $0.9B | $0.9B | $0.9B | 2 |
| Q2 FY2026 | $0.9B | $0.9B | $0.9B | 2 |
| Q1 FY2026 | $0.8B | $0.8B | $0.8B | 3 |
| Q4 FY2025 | $0.8B | $0.8B | $0.8B | 2 |
| Q3 FY2025 | $0.5B | $0.5B | $0.5B | 7 |
| Q2 FY2025 | $0.5B | $0.5B | $0.5B | 7 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 12, 2026 | — | $30.47 | $32.90 | +7.98% |
| ▼ Q2 FY2026 | May 12, 2026 | -64.7% | $30.47 | $32.90 | +7.98% |
| — Q3 FY2025 | Aug 7, 2025 | — | $53.25 | $53.25 | +0.00% |
| ▲ Q2 FY2025 | May 13, 2025 | +26.9% | $64.16 | $69.23 | +7.90% |
| — Q1 FY2025 | Feb 7, 2025 | — | $58.48 | $58.48 | +0.00% |
| — Q3 FY2024 | Sep 30, 2024 | — | $63.57 | $78.88 | +24.08% |
| ▼ Q3 FY2024 | Aug 6, 2024 | -30.9% | $67.00 | $67.00 | +0.00% |
| ▲ Q2 FY2024 | May 8, 2024 | +10.7% | $99.55 | $99.55 | +0.00% |
Q2 FY2026+7.98%
Report Date
May 12, 2026
EPS Beat/Miss
—
Price Before
$30.47
Price After
$32.90
Q2 FY2026+7.98%
Report Date
May 12, 2026
EPS Beat/Miss
-64.7%
Price Before
$30.47
Price After
$32.90
Q3 FY2025+0.00%
Report Date
Aug 7, 2025
EPS Beat/Miss
—
Price Before
$53.25
Price After
$53.25
Q2 FY2025+7.90%
Report Date
May 13, 2025
EPS Beat/Miss
+26.9%
Price Before
$64.16
Price After
$69.23
Q1 FY2025+0.00%
Report Date
Feb 7, 2025
EPS Beat/Miss
—
Price Before
$58.48
Price After
$58.48
Q3 FY2024+24.08%
Report Date
Sep 30, 2024
EPS Beat/Miss
—
Price Before
$63.57
Price After
$78.88
Q3 FY2024+0.00%
Report Date
Aug 6, 2024
EPS Beat/Miss
-30.9%
Price Before
$67.00
Price After
$67.00
Q2 FY2024+0.00%
Report Date
May 8, 2024
EPS Beat/Miss
+10.7%
Price Before
$99.55
Price After
$99.55
Avg Beat Reaction+3.95%
Avg Miss Reaction+3.99%
Beat Rate2 / 8 quarters
Largest Move+24.08% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CZMWF ends December
Carl Zeiss Meditec AG (CZMWF) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $0.38 (in line with the analyst consensus of —). The next CZMWF earnings date is expected around September 1, 2026.
Each quarter, investors track CZMWF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CZMWF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CZMWF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CZMWF earnings · 4 questionsCarl Zeiss Meditec AG's next earnings report is expected around September 1, 2026. CZMWF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CZMWF historically reports after market close (AMC).
CZMWF earnings datewhen is CZMWF earningsCZMWF next earnings datewhen does CZMWF report earningsCZMWF earnings calendar
▸ Source: FMP · Carl Zeiss Meditec AG SEC filings · US GAAP · Carl Zeiss Meditec AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026